Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2.

Pärnänen P, Meurman JH, Sorsa T.

Mycoses. 2011 Jul;54(4):325-30. doi: 10.1111/j.1439-0507.2010.01889.x. Epub 2010 Apr 6.

PMID:
20406392
2.

Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.

Biochem J. 2003 Jun 15;372(Pt 3):799-809.

3.

Complexes of gelatinases and tissue inhibitor of metalloproteinases in human seminal plasma.

Shimokawa K, Katayama M, Matsuda Y, Takahashi H, Hara I, Sato H.

J Androl. 2003 Jan-Feb;24(1):73-7.

4.

Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.

Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.

Exp Eye Res. 2002 May;74(5):577-84.

PMID:
12076079
6.
7.
8.
10.
11.

Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.

Eagleton MJ, Peterson DA, Sullivan VV, Roelofs KJ, Ford JA, Stanley JC, Upchurch GR Jr.

J Surg Res. 2002 May 1;104(1):15-21.

PMID:
11971672
12.
13.

Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.

Boveland SD, Moore PA, Mysore J, Krunkosky TM, Dietrich UM, Jarrett C, Paige Carmichael K.

Vet Ophthalmol. 2010 Mar;13(2):81-90. doi: 10.1111/j.1463-5224.2009.00757.x.

PMID:
20447025
14.

The inhibitory effect of preeclamptic umbilical cord blood serum on matrix metalloproteinase-1 in arterial slices incubated in vitro.

Galewska Z, Romanowicz L, Gogiel T, Jaworski S, Bańkowski E.

Pathobiology. 2006;73(6):310-6.

PMID:
17374969
15.

Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.

Fujimoto N, Ward RV, Shinya T, Iwata K, Yamashita K, Hayakawa T.

Biochem J. 1996 Feb 1;313 ( Pt 3):827-33.

16.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.

Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A.

J Orofac Pain. 2000 Winter;14(1):20-30.

PMID:
11203734
19.

Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.

Işlekel H, Oktay G, Terzi C, Canda AE, Füzün M, Küpelioğlu A.

Cell Biochem Funct. 2007 Jul-Aug;25(4):433-41.

PMID:
16615041
20.

Matrix metalloproteinases -2 and -9 and their endogenous tissue inhibitors in fetal membrane repair following fetoscopy in a rabbit model.

Devlieger R, Deprest JA, Gratacós E, Pijnenborg R, Leask R, Riley SC.

Mol Hum Reprod. 2000 May;6(5):479-85.

PMID:
10775654

Supplemental Content

Support Center